Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	ARID1A WBP2 SS18 SMARCC2 EP300 ZMIZ1	1.24e-06	303	24	6	GO:0003713
GeneOntologyMolecularFunction	chromatin binding	ARID1A ADNP WBP2 SMARCC2 GLI2 EP300 CHD7	1.84e-05	739	24	7	GO:0003682
GeneOntologyMolecularFunction	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	ATAT1 EP300	2.07e-05	6	24	2	GO:0004468
GeneOntologyMolecularFunction	transcription coregulator activity	ARID1A WBP2 SS18 SMARCC2 EP300 ZMIZ1	4.23e-05	562	24	6	GO:0003712
GeneOntologyMolecularFunction	chromatin DNA binding	WBP2 SMARCC2 GLI2 EP300	4.40e-05	167	24	4	GO:0031490
GeneOntologyMolecularFunction	promoter-specific chromatin binding	GLI2 EP300 CHD7	1.32e-04	83	24	3	GO:1990841
GeneOntologyMolecularFunction	molecular adaptor activity	ARID1A WBP2 SS18 SMARCC2 EP300 TAB3 ZMIZ1	8.13e-04	1356	24	7	GO:0060090
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	ARID1A CHD7	8.99e-04	37	24	2	GO:0140658
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ADNP PKNOX2 WBP2 FOXJ3 GLI2 EP300 CHD7	1.25e-03	1459	24	7	GO:0000977
GeneOntologyMolecularFunction	nuclear receptor binding	ARID1A WBP2 EP300	1.42e-03	187	24	3	GO:0016922
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	ATAT1 EP300	1.98e-03	55	24	2	GO:0061733
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	ARID1A WBP2 SS18 SMARCC2 EP300 ZMIZ1	2.07e-03	1160	24	6	GO:0030674
GeneOntologyMolecularFunction	transition metal ion binding	SEC24C ADNP GLI2 EP300 TAB3 ZMIZ1	2.34e-03	1189	24	6	GO:0046914
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	ATAT1 EP300	2.35e-03	60	24	2	GO:0034212
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	SS18 ZMIZ1	2.43e-03	61	24	2	GO:0030374
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	PKNOX2 WBP2 FOXJ3 GLI2 EP300 CHD7	2.94e-03	1244	24	6	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	PKNOX2 WBP2 FOXJ3 GLI2 EP300 CHD7	3.27e-03	1271	24	6	GO:0000987
GeneOntologyMolecularFunction	zinc ion binding	SEC24C GLI2 EP300 TAB3 ZMIZ1	3.66e-03	891	24	5	GO:0008270
GeneOntologyMolecularFunction	N-acetyltransferase activity	ATAT1 EP300	3.93e-03	78	24	2	GO:0008080
GeneOntologyMolecularFunction	SMAD binding	EP300 ZMIZ1	4.76e-03	86	24	2	GO:0046332
GeneOntologyMolecularFunction	nucleosome binding	ARID1A SMARCC2	6.13e-03	98	24	2	GO:0031491
GeneOntologyMolecularFunction	N-acyltransferase activity	ATAT1 EP300	6.63e-03	102	24	2	GO:0016410
GeneOntologyMolecularFunction	acetyltransferase activity	ATAT1 EP300	6.88e-03	104	24	2	GO:0016407
GeneOntologyMolecularFunction	beta-catenin binding	ADNP EP300	9.07e-03	120	24	2	GO:0008013
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	ARID1A CHD7	1.01e-02	127	24	2	GO:0008094
GeneOntologyMolecularFunction	acyltransferase activity	ATAT1 CBLL2 EP300 ZMIZ1	1.29e-02	775	24	4	GO:0016746
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	ARID1A WBP2 EP300	1.32e-02	417	24	3	GO:0061629
GeneOntologyBiologicalProcess	positive regulation of T cell differentiation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	5.91e-07	144	24	5	GO:0045582
GeneOntologyBiologicalProcess	positive regulation of lymphocyte differentiation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.06e-06	162	24	5	GO:0045621
GeneOntologyBiologicalProcess	T cell differentiation	ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	3.94e-06	382	24	6	GO:0030217
GeneOntologyBiologicalProcess	regulation of T cell differentiation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	5.42e-06	226	24	5	GO:0045580
GeneOntologyBiologicalProcess	positive regulation of leukocyte differentiation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	7.56e-06	242	24	5	GO:1902107
GeneOntologyBiologicalProcess	positive regulation of hemopoiesis	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	7.56e-06	242	24	5	GO:1903708
GeneOntologyBiologicalProcess	regulation of lymphocyte differentiation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.19e-05	266	24	5	GO:0045619
GeneOntologyBiologicalProcess	nuclear receptor-mediated steroid hormone signaling pathway	ARID1A WBP2 EP300 ZMIZ1	1.73e-05	136	24	4	GO:0030518
GeneOntologyBiologicalProcess	positive regulation of T cell activation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.81e-05	290	24	5	GO:0050870
GeneOntologyBiologicalProcess	regulation of cell development	ARID1A ADNP SMARCC2 GLI2 GORASP1 EP300 CHD7 ZMIZ1	2.11e-05	1095	24	8	GO:0060284
GeneOntologyBiologicalProcess	lymphocyte differentiation	ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.73e-05	537	24	6	GO:0030098
GeneOntologyBiologicalProcess	positive regulation of leukocyte cell-cell adhesion	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	2.78e-05	317	24	5	GO:1903039
GeneOntologyBiologicalProcess	androgen receptor signaling pathway	ARID1A EP300 ZMIZ1	2.78e-05	51	24	3	GO:0030521
GeneOntologyBiologicalProcess	steroid hormone receptor signaling pathway	ARID1A WBP2 EP300 ZMIZ1	2.90e-05	155	24	4	GO:0043401
GeneOntologyBiologicalProcess	chordate embryonic development	SEC24C ARID1A GLI2 EP300 CNOT3 CHD7 ZMIZ1	5.53e-05	906	24	7	GO:0043009
GeneOntologyBiologicalProcess	transcription initiation-coupled chromatin remodeling	ARID1A WBP2 EP300	5.77e-05	65	24	3	GO:0045815
GeneOntologyBiologicalProcess	positive regulation of cell development	ARID1A ADNP SMARCC2 GLI2 EP300 ZMIZ1	5.78e-05	614	24	6	GO:0010720
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	SEC24C ARID1A GLI2 EP300 CNOT3 CHD7 ZMIZ1	6.48e-05	929	24	7	GO:0009792
GeneOntologyBiologicalProcess	positive regulation of gene expression, epigenetic	ARID1A WBP2 EP300	6.60e-05	68	24	3	GO:0141137
GeneOntologyBiologicalProcess	positive regulation of lymphocyte activation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	7.00e-05	385	24	5	GO:0051251
GeneOntologyBiologicalProcess	mononuclear cell differentiation	ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	7.28e-05	640	24	6	GO:1903131
GeneOntologyBiologicalProcess	positive regulation of cell-cell adhesion	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	7.35e-05	389	24	5	GO:0022409
GeneOntologyBiologicalProcess	nuclear receptor-mediated signaling pathway	ARID1A WBP2 EP300 ZMIZ1	8.14e-05	202	24	4	GO:0141193
GeneOntologyBiologicalProcess	internal peptidyl-lysine acetylation	ATAT1 EP300	8.50e-05	12	24	2	GO:0018393
GeneOntologyBiologicalProcess	regulation of stem cell population maintenance	ARID1A SS18 CNOT3	9.94e-05	78	24	3	GO:2000036
GeneOntologyBiologicalProcess	intracellular receptor signaling pathway	ATAT1 ARID1A WBP2 EP300 ZMIZ1	1.01e-04	416	24	5	GO:0030522
GeneOntologyBiologicalProcess	positive regulation of leukocyte activation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.09e-04	423	24	5	GO:0002696
GeneOntologyBiologicalProcess	regulation of leukocyte differentiation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.17e-04	429	24	5	GO:1902105
GeneOntologyBiologicalProcess	T cell activation	ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	1.20e-04	701	24	6	GO:0042110
GeneOntologyBiologicalProcess	internal protein amino acid acetylation	ATAT1 EP300	1.35e-04	15	24	2	GO:0006475
GeneOntologyBiologicalProcess	regulation of leukocyte cell-cell adhesion	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.41e-04	447	24	5	GO:1903037
GeneOntologyBiologicalProcess	positive regulation of cell activation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.44e-04	449	24	5	GO:0050867
GeneOntologyBiologicalProcess	cellular response to steroid hormone stimulus	ARID1A WBP2 EP300 ZMIZ1	1.56e-04	239	24	4	GO:0071383
GeneOntologyBiologicalProcess	regulation of T cell activation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.58e-04	458	24	5	GO:0050863
GeneOntologyBiologicalProcess	chromatin remodeling	ARID1A WBP2 SS18 SMARCC2 EP300 CHD7	1.63e-04	741	24	6	GO:0006338
GeneOntologyBiologicalProcess	hormone-mediated signaling pathway	ARID1A WBP2 EP300 ZMIZ1	1.69e-04	244	24	4	GO:0009755
GeneOntologyBiologicalProcess	COPII-coated vesicle cargo loading	SEC24C SEC31A	1.96e-04	18	24	2	GO:0090110
GeneOntologyBiologicalProcess	leukocyte cell-cell adhesion	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	2.09e-04	486	24	5	GO:0007159
GeneOntologyBiologicalProcess	forebrain development	ATAT1 ARID1A GLI2 CHD7 ZMIZ1	2.15e-04	489	24	5	GO:0030900
GeneOntologyBiologicalProcess	leukocyte differentiation	ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.29e-04	789	24	6	GO:0002521
GeneOntologyBiologicalProcess	negative regulation of autophagy	EIF4G3 EP300 TAB3	2.90e-04	112	24	3	GO:0010507
GeneOntologyBiologicalProcess	nucleosome disassembly	ARID1A SMARCC2	2.96e-04	22	24	2	GO:0006337
GeneOntologyBiologicalProcess	leukocyte activation	ARID1A SMARCC2 CD99 GLI2 EP300 CHD7 ZMIZ1	2.97e-04	1186	24	7	GO:0045321
GeneOntologyBiologicalProcess	regulation of hemopoiesis	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	3.40e-04	540	24	5	GO:1903706
GeneOntologyBiologicalProcess	protein-DNA complex disassembly	ARID1A SMARCC2	3.53e-04	24	24	2	GO:0032986
GeneOntologyBiologicalProcess	positive regulation of immune system process	ATAT1 ARID1A SMARCC2 CD99 GLI2 EP300 ZMIZ1	3.94e-04	1242	24	7	GO:0002684
GeneOntologyBiologicalProcess	chromatin organization	ARID1A WBP2 SS18 SMARCC2 EP300 CHD7	4.54e-04	896	24	6	GO:0006325
GeneOntologyBiologicalProcess	positive regulation of cell adhesion	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	4.68e-04	579	24	5	GO:0045785
GeneOntologyBiologicalProcess	regulation of cell-cell adhesion	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	4.71e-04	580	24	5	GO:0022407
GeneOntologyBiologicalProcess	peptidyl-lysine acetylation	ATAT1 EP300	4.81e-04	28	24	2	GO:0018394
GeneOntologyBiologicalProcess	regulation of nucleotide-excision repair	ARID1A SMARCC2	5.17e-04	29	24	2	GO:2000819
GeneOntologyBiologicalProcess	head development	ATAT1 ARID1A GLI2 EP300 CHD7 ZMIZ1	5.19e-04	919	24	6	GO:0060322
GeneOntologyBiologicalProcess	in utero embryonic development	SEC24C GLI2 CNOT3 CHD7 ZMIZ1	5.34e-04	596	24	5	GO:0001701
GeneOntologyBiologicalProcess	regulation of cell adhesion	ARID1A CBLL2 SMARCC2 GLI2 EP300 ZMIZ1	5.44e-04	927	24	6	GO:0030155
GeneOntologyBiologicalProcess	cellular response to organic cyclic compound	ARID1A WBP2 GLI2 EP300 ZMIZ1	5.71e-04	605	24	5	GO:0071407
GeneOntologyBiologicalProcess	regulation of lymphocyte activation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	6.11e-04	614	24	5	GO:0051249
GeneOntologyBiologicalProcess	regulation of nervous system development	ADGRB2 ADNP GORASP1 EP300 CHD7	6.62e-04	625	24	5	GO:0051960
GeneOntologyBiologicalProcess	cell activation	ARID1A SMARCC2 CD99 GLI2 EP300 CHD7 ZMIZ1	6.70e-04	1356	24	7	GO:0001775
GeneOntologyBiologicalProcess	positive regulation of translation	EIF4G3 RBMS3 EP300	6.95e-04	151	24	3	GO:0045727
GeneOntologyBiologicalProcess	lymphocyte activation	ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	7.14e-04	976	24	6	GO:0046649
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	WBP2 FOXJ3 SS18 GLI2 EP300 CHD7 ZMIZ1	7.77e-04	1390	24	7	GO:0045944
GeneOntologyBiologicalProcess	vesicle cargo loading	SEC24C SEC31A	7.98e-04	36	24	2	GO:0035459
GeneOntologyBiologicalProcess	protein-DNA complex organization	ARID1A WBP2 SS18 SMARCC2 EP300 CHD7	8.07e-04	999	24	6	GO:0071824
GeneOntologyBiologicalProcess	peptidyl-lysine modification	ATAT1 EP300 ZMIZ1	8.53e-04	162	24	3	GO:0018205
GeneOntologyBiologicalProcess	response to steroid hormone	ARID1A WBP2 EP300 ZMIZ1	9.09e-04	381	24	4	GO:0048545
GeneOntologyBiologicalProcess	embryo development	SEC24C ARID1A GLI2 EP300 CNOT3 CHD7 ZMIZ1	9.47e-04	1437	24	7	GO:0009790
GeneOntologyBiologicalProcess	positive regulation of collagen biosynthetic process	GLI2 EP300	1.03e-03	41	24	2	GO:0032967
GeneOntologyBiologicalProcess	regulation of leukocyte activation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.06e-03	694	24	5	GO:0002694
GeneOntologyBiologicalProcess	regulation of G0 to G1 transition	ARID1A SMARCC2	1.09e-03	42	24	2	GO:0070316
GeneOntologyBiologicalProcess	positive regulation of collagen metabolic process	GLI2 EP300	1.19e-03	44	24	2	GO:0010714
GeneOntologyBiologicalProcess	G0 to G1 transition	ARID1A SMARCC2	1.19e-03	44	24	2	GO:0045023
GeneOntologyBiologicalProcess	cell-cell adhesion	ARID1A SMARCC2 CD99 GLI2 EP300 ZMIZ1	1.19e-03	1077	24	6	GO:0098609
GeneOntologyBiologicalProcess	COPII-coated vesicle budding	SEC24C SEC31A	1.25e-03	45	24	2	GO:0090114
GeneOntologyBiologicalProcess	transcription initiation at RNA polymerase II promoter	ARID1A WBP2 EP300	1.27e-03	186	24	3	GO:0006367
GeneOntologyBiologicalProcess	regulation of cell activation	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	1.55e-03	756	24	5	GO:0050865
GeneOntologyBiologicalProcess	heart development	ARID1A GLI2 EP300 CHD7 ZMIZ1	1.56e-03	757	24	5	GO:0007507
GeneOntologyBiologicalProcess	positive regulation of stem cell population maintenance	ARID1A SS18	1.60e-03	51	24	2	GO:1902459
GeneOntologyBiologicalProcess	positive regulation of cell differentiation	ARID1A ADNP SMARCC2 GLI2 EP300 ZMIZ1	1.61e-03	1141	24	6	GO:0045597
GeneOntologyBiologicalProcess	positive regulation of myoblast differentiation	ARID1A SMARCC2	1.79e-03	54	24	2	GO:0045663
GeneOntologyBiologicalProcess	positive regulation of axon extension	ADNP EP300	1.86e-03	55	24	2	GO:0045773
GeneOntologyBiologicalProcess	estrogen receptor signaling pathway	ARID1A WBP2	1.99e-03	57	24	2	GO:0030520
GeneOntologyBiologicalProcess	hemopoiesis	ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.29e-03	1223	24	6	GO:0030097
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	ARID1A WBP2 EP300	2.36e-03	231	24	3	GO:0006352
GeneOntologyBiologicalProcess	regulation of translation	EIF4G3 RBMS3 EP300 CNOT3	2.36e-03	494	24	4	GO:0006417
GeneOntologyBiologicalProcess	face development	EP300 CHD7	2.43e-03	63	24	2	GO:0060324
GeneOntologyBiologicalProcess	stem cell population maintenance	ARID1A SS18 CNOT3	2.54e-03	237	24	3	GO:0019827
GeneOntologyBiologicalProcess	positive regulation of developmental growth	ADNP EP300 CHD7	2.57e-03	238	24	3	GO:0048639
GeneOntologyBiologicalProcess	regulation of collagen biosynthetic process	GLI2 EP300	2.58e-03	65	24	2	GO:0032965
GeneOntologyBiologicalProcess	maintenance of cell number	ARID1A SS18 CNOT3	2.69e-03	242	24	3	GO:0098727
GeneOntologyBiologicalProcess	brain development	ATAT1 ARID1A GLI2 CHD7 ZMIZ1	2.72e-03	859	24	5	GO:0007420
GeneOntologyBiologicalProcess	regulation of neurogenesis	ADNP GORASP1 EP300 CHD7	2.74e-03	515	24	4	GO:0050767
GeneOntologyBiologicalProcess	protein acetylation	ATAT1 EP300	2.82e-03	68	24	2	GO:0006473
GeneOntologyCellularComponent	npBAF complex	ARID1A SS18 SMARCC2	4.80e-07	14	24	3	GO:0071564
GeneOntologyCellularComponent	SWI/SNF complex	ARID1A SS18 SMARCC2	5.29e-06	30	24	3	GO:0016514
GeneOntologyCellularComponent	chromatin	ARID1A ADNP WBP2 FOXJ3 SS18 SMARCC2 EP300 CHD7 ZMIZ1	2.15e-05	1480	24	9	GO:0000785
GeneOntologyCellularComponent	bBAF complex	ARID1A SMARCC2	5.65e-05	10	24	2	GO:0140092
GeneOntologyCellularComponent	brahma complex	ARID1A SMARCC2	1.14e-04	14	24	2	GO:0035060
GeneOntologyCellularComponent	nBAF complex	ARID1A SMARCC2	1.50e-04	16	24	2	GO:0071565
GeneOntologyCellularComponent	COPII vesicle coat	SEC24C SEC31A	1.50e-04	16	24	2	GO:0030127
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	ARID1A SS18 SMARCC2	1.77e-04	96	24	3	GO:0070603
GeneOntologyCellularComponent	ATPase complex	ARID1A SS18 SMARCC2	4.23e-04	129	24	3	GO:1904949
GeneOntologyCellularComponent	endoplasmic reticulum exit site	SEC24C SEC31A	1.06e-03	42	24	2	GO:0070971
GeneOntologyCellularComponent	ER to Golgi transport vesicle membrane	SEC24C SEC31A	2.44e-03	64	24	2	GO:0012507
GeneOntologyCellularComponent	vesicle coat	SEC24C SEC31A	2.67e-03	67	24	2	GO:0030120
GeneOntologyCellularComponent	membrane coat	SEC24C SEC31A	6.54e-03	106	24	2	GO:0030117
GeneOntologyCellularComponent	coated membrane	SEC24C SEC31A	6.54e-03	106	24	2	GO:0048475
GeneOntologyCellularComponent	COPII-coated ER to Golgi transport vesicle	SEC24C SEC31A	7.02e-03	110	24	2	GO:0030134
HumanPheno	Feeding difficulties in infancy	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 ZMIZ1	1.67e-07	594	11	9	HP:0008872
HumanPheno	Feeding difficulties	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 SEC31A ZMIZ1	6.21e-07	982	11	10	HP:0002022
HumanPheno	Abnormal cerebral ventricle morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 SEC31A ZMIZ1	1.15e-06	1046	11	10	HP:0002118
HumanPheno	Hyperactivity	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.42e-06	558	11	8	HP:0000752
HumanPheno	Prenatal growth deficiency	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A	6.23e-06	631	11	8	HP:0001515
HumanPheno	Intrauterine growth retardation	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A	6.23e-06	631	11	8	HP:0001511
HumanPheno	Abnormal lip morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 SEC31A ZMIZ1	6.54e-06	1249	11	10	HP:0000159
HumanPheno	Abnormality of mouth size	SEC24C ARID1A ADNP SMARCC2 EP300 CHD7 ZMIZ1	6.59e-06	425	11	7	HP:0011337
HumanPheno	Autistic behavior	SEC24C ARID1A ADNP SMARCC2 EP300 CNOT3 CHD7 ZMIZ1	1.08e-05	678	11	8	HP:0000729
HumanPheno	Abnormal upper lip morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 ZMIZ1	1.32e-05	980	11	9	HP:0000177
HumanPheno	Aplasia/hypoplasia involving the skeleton	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 SEC31A ZMIZ1	1.33e-05	1343	11	10	HP:0009115
HumanPheno	Abnormality of the philtrum	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 ZMIZ1	1.82e-05	726	11	8	HP:0000288
HumanPheno	Abnormal eyelid morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 SEC31A ZMIZ1	2.10e-05	1408	11	10	HP:0000492
HumanPheno	Abnormality of the helix	SEC24C GLI2 EP300 CHD7 ZMIZ1	2.20e-05	183	11	5	HP:0000380
HumanPheno	Abnormal 5th finger morphology	ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7	2.20e-05	509	11	7	HP:0004207
HumanPheno	Diagnostic behavioral phenotype	SEC24C ARID1A ADNP SMARCC2 EP300 CNOT3 CHD7 ZMIZ1	2.26e-05	747	11	8	HP:0025783
HumanPheno	Tetralogy of Fallot	SEC24C ARID1A SMARCC2 GLI2 CHD7	2.32e-05	185	11	5	HP:0001636
HumanPheno	Aggressive behavior	ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.41e-05	516	11	7	HP:0000718
HumanPheno	Abnormal aggressive, impulsive or violent behavior	ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.41e-05	516	11	7	HP:0006919
HumanPheno	Ptosis	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.42e-05	754	11	8	HP:0000508
HumanPheno	Congenital malformation of the great arteries	SEC24C ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.85e-05	529	11	7	HP:0011603
HumanPheno	Aplasia/Hypoplasia of the corpus callosum	ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 SEC31A ZMIZ1	2.90e-05	772	11	8	HP:0007370
HumanPheno	Abnormal hand morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 ZMIZ1	3.10e-05	1082	11	9	HP:0005922
HumanPheno	Cryptorchidism	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	3.13e-05	780	11	8	HP:0000028
HumanPheno	Aplasia/hypoplasia involving bones of the hand	ARID1A ADNP SMARCC2 EP300 CNOT3 CHD7 ZMIZ1	3.19e-05	538	11	7	HP:0005927
HumanPheno	Joint hypermobility	SEC24C ARID1A ADNP SMARCC2 EP300 CHD7 ZMIZ1	4.01e-05	557	11	7	HP:0001382
HumanPheno	Disinhibition	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	4.05e-05	807	11	8	HP:0000734
HumanPheno	Inappropriate behavior	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	4.05e-05	807	11	8	HP:0000719
HumanPheno	Abnormal response to social norms	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	4.05e-05	807	11	8	HP:5200123
HumanPheno	Social disinhibition	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	4.05e-05	807	11	8	HP:5200029
HumanPheno	Aspiration	ADNP EP300 SEC31A	4.32e-05	34	11	3	HP:0002835
HumanPheno	Abnormal testis morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	4.45e-05	1129	11	9	HP:0000035
HumanPheno	Abnormal helix morphology	SEC24C GLI2 EP300 CHD7 ZMIZ1	4.48e-05	212	11	5	HP:0011039
HumanPheno	Non-obstructive azoospermia	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	4.55e-05	1132	11	9	HP:0011961
HumanPheno	Aplasia/hypoplasia involving bones of the upper limbs	ARID1A ADNP SMARCC2 EP300 CNOT3 CHD7 ZMIZ1	4.78e-05	572	11	7	HP:0006496
HumanPheno	Abnormal posterior cranial fossa morphology	ARID1A SMARCC2 EP300 CNOT3 CHD7	5.48e-05	221	11	5	HP:0000932
HumanPheno	Azoospermia	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	5.49e-05	1157	11	9	HP:0000027
HumanPheno	Strabismus	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 ZMIZ1	5.57e-05	1159	11	9	HP:0000486
HumanPheno	Patent ductus arteriosus	SEC24C ARID1A SMARCC2 EP300 CHD7 ZMIZ1	5.72e-05	382	11	6	HP:0001643
HumanPheno	Feeding difficulties	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 ZMIZ1	5.95e-05	1168	11	9	HP:0011968
HumanPheno	Abnormal spermatogenesis	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	6.97e-05	1190	11	9	HP:0008669
HumanPheno	Thin corpus callosum	ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 SEC31A ZMIZ1	7.01e-05	868	11	8	HP:0033725
HumanPheno	Abnormally increased volition	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	7.07e-05	869	11	8	HP:5200263
HumanPheno	Abnormal conjugate eye movement	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 ZMIZ1	7.38e-05	1198	11	9	HP:0000549
HumanPheno	Short toe	ADNP EP300 CHD7 ZMIZ1	7.45e-05	116	11	4	HP:0001831
HumanPheno	Abnormality of dental eruption	ARID1A ADNP SMARCC2 EP300 CHD7	8.15e-05	240	11	5	HP:0006292
HumanPheno	Abnormal skull base morphology	ARID1A SMARCC2 EP300 CNOT3 CHD7	8.48e-05	242	11	5	HP:0002693
HumanPheno	Abnormal facial shape	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 SEC31A	8.67e-05	1221	11	9	HP:0001999
HumanPheno	Abnormal social development	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	9.82e-05	908	11	8	HP:0025732
HumanPheno	Abnormal male internal genitalia morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	1.01e-04	1243	11	9	HP:0000022
HumanPheno	Abnormal external nose morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 ZMIZ1	1.05e-04	916	11	8	HP:0010938
HumanPheno	Brachydactyly (hand)	ARID1A ADNP SMARCC2 EP300 CHD7 ZMIZ1	1.12e-04	430	11	6	HP:0100667
HumanPheno	Long eyelashes	ARID1A SMARCC2 EP300 SEC31A	1.13e-04	129	11	4	HP:0000527
HumanPheno	Complex cardiac malformations	SEC24C ARID1A SMARCC2 GLI2 CHD7	1.13e-04	257	11	5	HP:0002565
HumanPheno	Functional abnormality of male internal genitalia	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	1.20e-04	1269	11	9	HP:0000025
HumanPheno	Abnormal corpus callosum morphology	ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 SEC31A ZMIZ1	1.24e-04	937	11	8	HP:0001273
HumanPheno	Conotruncal defect	SEC24C ARID1A SMARCC2 GLI2 CHD7	1.29e-04	264	11	5	HP:0001710
HumanPheno	Thick lower lip vermilion	ARID1A ADNP SMARCC2 GLI2	1.39e-04	136	11	4	HP:0000179
HumanPheno	Coloboma	ADNP GLI2 EP300 CHD7 ZMIZ1	1.53e-04	274	11	5	HP:0000589
HumanPheno	Aplasia/Hypoplasia of toe	ADNP EP300 CHD7 ZMIZ1	1.55e-04	140	11	4	HP:0001991
HumanPheno	Abnormal male reproductive system physiology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	1.61e-04	1314	11	9	HP:0012874
HumanPheno	Aplasia/Hypoplasia of the earlobes	SEC24C EP300 CHD7	1.65e-04	53	11	3	HP:0009906
HumanPheno	Thick vermilion border	ARID1A ADNP SMARCC2 GLI2 SEC31A	1.67e-04	279	11	5	HP:0012471
HumanPheno	Abnormal ventriculoarterial connection	SEC24C ARID1A SMARCC2 GLI2 CHD7	1.70e-04	280	11	5	HP:0011563
HumanPheno	Abnormality of upper lip vermillion	ARID1A ADNP SMARCC2 GLI2 EP300 ZMIZ1	1.72e-04	464	11	6	HP:0011339
HumanPheno	Abnormal thorax morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	1.76e-04	1328	11	9	HP:0000765
HumanPheno	Abnormal male external genitalia morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	1.77e-04	1329	11	9	HP:0000032
HumanPheno	Abnormal connection of the cardiac segments	SEC24C ARID1A SMARCC2 GLI2 CHD7	1.82e-04	284	11	5	HP:0011545
HumanPheno	Abnormal midface morphology	SEC24C ADNP GLI2 EP300 CNOT3 CHD7 ZMIZ1	1.86e-04	704	11	7	HP:0000309
HumanPheno	Abnormal penis morphology	SEC24C ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.00e-04	712	11	7	HP:0000036
HumanPheno	Abnormal joint physiology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	2.13e-04	1358	11	9	HP:0034430
HumanPheno	Abnormality of joint mobility	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	2.13e-04	1358	11	9	HP:0011729
HumanPheno	Abnormality of the hairline	ARID1A ADNP SMARCC2 EP300 CNOT3	2.14e-04	294	11	5	HP:0009553
HumanPheno	Abnormal external genitalia	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	2.32e-04	1372	11	9	HP:0000811
HumanPheno	Prominent lips	ARID1A ADNP SMARCC2 GLI2	2.36e-04	156	11	4	HP:0000184
HumanPheno	Abnormal morphology of the great vessels	SEC24C ARID1A SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.48e-04	736	11	7	HP:0030962
HumanPheno	Abnormal nasal bridge morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.49e-04	1029	11	8	HP:0000422
HumanPheno	Abnormal finger morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 ZMIZ1	2.51e-04	1385	11	9	HP:0001167
HumanPheno	Reduced impulse control	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	2.54e-04	1032	11	8	HP:5200045
HumanPheno	Broad nasal tip	ARID1A ADNP SMARCC2 GLI2	2.54e-04	159	11	4	HP:0000455
HumanPheno	Hernia of the abdominal wall	SEC24C ARID1A ADNP SMARCC2 CHD7 SEC31A	2.79e-04	506	11	6	HP:0004299
HumanPheno	Pneumonia	ARID1A SMARCC2 GLI2 EP300 CHD7	2.80e-04	311	11	5	HP:0002090
HumanPheno	Inguinal hernia	SEC24C ARID1A ADNP SMARCC2 SEC31A	2.84e-04	312	11	5	HP:0000023
HumanPheno	Ventricular septal defect	SEC24C ARID1A SMARCC2 EP300 CHD7 SEC31A	2.91e-04	510	11	6	HP:0001629
HumanPheno	Abdominal wall defect	SEC24C ARID1A ADNP SMARCC2 CHD7 SEC31A	2.94e-04	511	11	6	HP:0010866
HumanPheno	Thoracoabdominal wall defect	SEC24C ARID1A ADNP SMARCC2 CHD7 SEC31A	2.94e-04	511	11	6	HP:0100656
HumanPheno	Aplasia involving bones of the extremities	ARID1A ADNP SMARCC2 EP300 CNOT3 CHD7 ZMIZ1	3.03e-04	759	11	7	HP:0009825
HumanPheno	Aplasia/hypoplasia involving bones of the extremities	ARID1A ADNP SMARCC2 EP300 CNOT3 CHD7 ZMIZ1	3.08e-04	761	11	7	HP:0045060
HumanPheno	Gastroesophageal reflux	SEC24C ADNP GLI2 EP300 CHD7 SEC31A	3.14e-04	517	11	6	HP:0002020
HumanPheno	Short attention span	SEC24C ADNP GLI2 EP300 CHD7 ZMIZ1	3.14e-04	517	11	6	HP:0000736
HumanPheno	Abnormal hair morphology	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CNOT3 CHD7 SEC31A	3.17e-04	1424	11	9	HP:0001595
HumanPheno	Abnormality of the pharynx	SEC24C ARID1A ADNP SMARCC2 EP300	3.20e-04	320	11	5	HP:0000600
HumanPheno	Abnormal ventricular septum morphology	SEC24C ARID1A SMARCC2 EP300 CHD7 SEC31A	3.28e-04	521	11	6	HP:0010438
HumanPheno	Abnormality of the male genitalia	SEC24C ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 SEC31A ZMIZ1	3.42e-04	1437	11	9	HP:0010461
HumanPheno	Short finger	ARID1A SMARCC2 EP300 CHD7 ZMIZ1	3.44e-04	325	11	5	HP:0009381
HumanPheno	Reduced attention regulation	SEC24C ADNP GLI2 EP300 CHD7 ZMIZ1	3.46e-04	526	11	6	HP:5200044
HumanPheno	Congenital abnormal hair pattern	ARID1A ADNP SMARCC2 EP300 CNOT3	3.54e-04	327	11	5	HP:0011361
HumanPheno	Hypoplastic facial bones	SEC24C GLI2 EP300 CNOT3 CHD7	3.75e-04	331	11	5	HP:0002692
HumanPheno	Aplasia/Hypoplasia of facial bones	SEC24C GLI2 EP300 CNOT3 CHD7	3.80e-04	332	11	5	HP:0034261
HumanPheno	Hypoplastic fifth fingernail	ARID1A SMARCC2	3.80e-04	14	11	2	HP:0008398
Domain	CHROMO	SMARCC2 CHD7	7.48e-04	33	23	2	SM00298
Domain	Chromo/shadow_dom	SMARCC2 CHD7	7.48e-04	33	23	2	IPR000953
Domain	SANT	SMARCC2 CHD7	1.71e-03	50	23	2	SM00717
Domain	SANT/Myb	SMARCC2 CHD7	1.85e-03	52	23	2	IPR001005
Domain	-	ADNP PKNOX2 SMARCC2	4.87e-03	283	23	3	1.10.10.60
Domain	Homeodomain-like	ADNP PKNOX2 SMARCC2	7.57e-03	332	23	3	IPR009057
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A SMARCC2 EP300	3.48e-06	24	18	3	M13404
Pathway	WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1	ARID1A SMARCC2 GLI2	7.68e-06	31	18	3	M39522
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	ARID1A SMARCC2 EP300	1.02e-05	34	18	3	MM15531
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	ARID1A SMARCC2 EP300	1.32e-05	37	18	3	M27797
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION	ARID1A SS18 SMARCC2	1.95e-05	42	18	3	M48237
Pathway	REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT	SEC24C GORASP1 SEC31A	8.69e-05	69	18	3	M27113
Pathway	KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION	SEC24C SEC31A	1.01e-04	12	18	2	M47770
Pathway	BIOCARTA_HSWI_SNF_PATHWAY	ARID1A SMARCC2	1.01e-04	12	18	2	M22006
Pathway	REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT	SEC24C GORASP1 SEC31A	1.51e-04	83	18	3	MM14819
Pathway	REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION	ARID1A SS18 SMARCC2	2.25e-04	95	18	3	M48268
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	ARID1A SS18 SMARCC2	2.39e-04	97	18	3	M48262
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	ARID1A SS18 SMARCC2 EP300	2.58e-04	254	18	4	M27131
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A EP300	3.50e-04	22	18	2	MM1370
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	SEC24C SEC31A	4.54e-04	25	18	2	MM15713
Pathway	WP_KLEEFSTRA_SYNDROME	ARID1A SMARCC2	6.13e-04	29	18	2	M48076
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	SEC24C SEC31A	6.13e-04	29	18	2	M1062
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	ARID1A SS18 SMARCC2	6.58e-04	137	18	3	M48232
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	ARID1A SS18 SMARCC2	7.31e-04	142	18	3	M48257
Pathway	KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY	ARID1A SMARCC2	8.94e-04	35	18	2	M47969
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	ARID1A SMARCC2 EP300	9.08e-04	153	18	3	MM15522
Pathway	REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT	SEC24C GORASP1 SEC31A	9.60e-04	156	18	3	M27097
Pathway	REACTOME_RMTS_METHYLATE_HISTONE_ARGININES	ARID1A SMARCC2	1.17e-03	40	18	2	MM14936
Pathway	REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT	SEC24C GORASP1 SEC31A	1.19e-03	168	18	3	MM14785
Pathway	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	SEC24C GORASP1 SEC31A	1.62e-03	187	18	3	M961
Pathway	REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES	EP300 CNOT3	1.75e-03	49	18	2	M27614
Pathway	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	SEC24C GORASP1 SEC31A	2.02e-03	202	18	3	MM15650
Pubmed	Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex.	ARID1A ADNP SMARCC2	1.15e-09	4	24	3	17878164
Pubmed	RNF138 inhibits late inflammatory gene transcription through degradation of SMARCC1 of the SWI/SNF complex.	EIF4G3 ARID1A ADNP SMARCC2	4.09e-09	29	24	4	36800290
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	EIF4G3 ADNP PKNOX2 WBP2 FOXJ3 GLI2 CHD7	1.21e-08	430	24	7	35044719
Pubmed	Human transcription factor protein interaction networks.	ARID1A ADNP SS18 SMARCC2 GLI2 EP300 CNOT3 CHD7 TAB3 ZMIZ1	1.54e-08	1429	24	10	35140242
Pubmed	Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor.	SEC24C ARID1A SMARCC2 SEC31A	3.93e-08	50	24	4	27716508
Pubmed	SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.	ARID1A SS18 SMARCC2	6.33e-08	12	24	3	11734557
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	ARID1A SS18 SMARCC2 EP300 CHD7	6.97e-08	157	24	5	30186101
Pubmed	Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.	ARID1A SS18 SMARCC2	1.31e-07	15	24	3	23785148
Pubmed	TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation.	ARID1A SMARCC2 EP300	2.34e-07	18	24	3	28068325
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	ARID1A ADNP SS18 SMARCC2 EP300 CHD7	2.95e-07	411	24	6	35182466
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	ARID1A ADNP EP300 CHD7	3.09e-07	83	24	4	28794006
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EIF4G3 ATAT1 ARID1A PKNOX2 FOXJ3 CD99 GLI2 EP300 ZMIZ1	3.44e-07	1489	24	9	28611215
Pubmed	p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion.	SS18 EP300	4.56e-07	2	24	2	11030627
Pubmed	FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.	ARID1A SS18 SMARCC2	5.07e-07	23	24	3	30962207
Pubmed	Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.	ARID1A SS18 SMARCC2	8.35e-07	27	24	3	29374058
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	ARID1A FOXJ3 CD99 GLI2 CHD7 SEC31A	1.39e-06	536	24	6	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	ARID1A FOXJ3 CD99 GLI2 CHD7 SEC31A	1.42e-06	538	24	6	10512203
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	ARID1A ADNP SMARCC2 EP300	1.93e-06	131	24	4	34551306
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	EIF4G3 ADGRB2 RBMS3 FOXJ3 GORASP1 CNOT3 SEC31A	2.14e-06	925	24	7	28986522
Pubmed	Quantitative trait loci affecting the 3D skull shape and size in mouse and prioritization of candidate genes in-silico.	ARID1A GLI2 CHD7	2.60e-06	39	24	3	25859222
Pubmed	Structural basis for cargo regulation of COPII coat assembly.	SEC24C SEC31A	2.74e-06	4	24	2	18692470
Pubmed	ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation.	ARID1A EP300	2.74e-06	4	24	2	33176148
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	ARID1A SMARCC2 EP300	2.80e-06	40	24	3	34585037
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	FOXJ3 EP300 TAB3 ZMIZ1	3.48e-06	152	24	4	38360978
Pubmed	Interaction network of human early embryonic transcription factors.	ARID1A SMARCC2 EP300 CHD7 ZMIZ1	3.69e-06	351	24	5	38297188
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARID1A FOXJ3 SS18 SMARCC2 EP300 CHD7	3.78e-06	638	24	6	31182584
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	EIF4G3 SEC24C ARID1A ADNP SMARCC2 CHD7	4.32e-06	653	24	6	22586326
Pubmed	The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.	ARID1A SMARCC2	4.56e-06	5	24	2	18086889
Pubmed	p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes.	ARID1A SMARCC2	4.56e-06	5	24	2	9584200
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	EIF4G3 SEC24C ARID1A SMARCC2 CNOT3	4.77e-06	370	24	5	22922362
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	ARID1A ADNP SMARCC2 EP300	6.51e-06	178	24	4	27637333
Pubmed	Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.	ARID1A SMARCC2 CHD7	6.61e-06	53	24	3	21532573
Pubmed	The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest.	ARID1A SMARCC2	6.83e-06	6	24	2	16230384
Pubmed	Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes.	ARID1A SMARCC2	6.83e-06	6	24	2	19650111
Pubmed	Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex.	ARID1A SMARCC2	6.83e-06	6	24	2	16940996
Pubmed	The SWI/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-β signaling.	ARID1A SMARCC2 EP300	7.40e-06	55	24	3	35945219
Pubmed	Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter.	SMARCC2 EP300	9.56e-06	7	24	2	16601680
Pubmed	Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.	ARID1A SS18	9.56e-06	7	24	2	23540691
Pubmed	A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.	ARID1A SS18 SMARCC2	1.01e-05	61	24	3	20305087
Pubmed	Loss of BAF (mSWI/SNF) Complexes Causes Global Transcriptional and Chromatin State Changes in Forebrain Development.	ARID1A SS18 SMARCC2	1.23e-05	65	24	3	26655900
Pubmed	CHD7 cooperates with PBAF to control multipotent neural crest formation.	SMARCC2 CHD7	1.27e-05	8	24	2	20130577
Pubmed	The assembly of mammalian SWI/SNF chromatin remodeling complexes is regulated by lysine-methylation dependent proteolysis.	ARID1A SMARCC2	1.27e-05	8	24	2	36335117
Pubmed	Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development.	ARID1A SMARCC2	1.27e-05	8	24	2	26986003
Pubmed	Coffin-Siris Syndrome	ARID1A SMARCC2	1.64e-05	9	24	2	23556151
Pubmed	Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B.	ARID1A SMARCC2	1.64e-05	9	24	2	20086098
Pubmed	The BAF chromatin complex component SMARCC1 does not mediate GLI transcriptional repression of Hedgehog target genes in limb buds.	ARID1A SMARCC2	1.64e-05	9	24	2	37805104
Pubmed	Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling.	ARID1A SMARCC2	1.64e-05	9	24	2	9845365
Pubmed	The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope.	SEC24C SEC31A	2.05e-05	10	24	2	17499046
Pubmed	Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner.	ARID1A SMARCC2	2.05e-05	10	24	2	12665591
Pubmed	EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis.	ARID1A EP300	2.05e-05	10	24	2	35210568
Pubmed	A methylation-mediator complex in hormone signaling.	ARID1A SMARCC2	2.05e-05	10	24	2	14729568
Pubmed	Structural basis of cargo membrane protein discrimination by the human COPII coat machinery.	SEC24C SEC31A	2.05e-05	10	24	2	18843296
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	ARID1A SMARCC2 CHD7	2.12e-05	78	24	3	28611094
Pubmed	Functional selectivity of recombinant mammalian SWI/SNF subunits.	ARID1A SMARCC2	2.50e-05	11	24	2	11018012
Pubmed	Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.	ARID1A SMARCC2	2.50e-05	11	24	2	18003620
Pubmed	Global proteomics of Ubqln2-based murine models of ALS.	SEC24C WBP2 SS18 TAB3	2.93e-05	261	24	4	33277362
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ARID1A ADNP WBP2 EP300 TAB3	3.19e-05	549	24	5	38280479
Pubmed	Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.	ARID1A SMARCC2	3.54e-05	13	24	2	11726552
Pubmed	Separation and Quantification of Some Alkaloids from Fumaria parviflora by Capillary Isotachophoresis1.	ARID1A SMARCC2	3.54e-05	13	24	2	17340523
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SEC24C ADGRB2 ADNP SMARCC2 CHD7 SEC31A	3.89e-05	963	24	6	28671696
Pubmed	Purification and biochemical heterogeneity of the mammalian SWI-SNF complex.	ARID1A SMARCC2	4.13e-05	14	24	2	8895581
Pubmed	Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.	SS18 SMARCC2	4.13e-05	14	24	2	36289231
Pubmed	Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation.	ARID1A SMARCC2	4.77e-05	15	24	2	11175787
Pubmed	PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes.	ARID1A SMARCC2	4.77e-05	15	24	2	15985610
Pubmed	An essential switch in subunit composition of a chromatin remodeling complex during neural development.	ARID1A SMARCC2	4.77e-05	15	24	2	17640523
Pubmed	Regulation of dendritic development by neuron-specific chromatin remodeling complexes.	ARID1A SMARCC2	4.77e-05	15	24	2	17920018
Pubmed	The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression.	ARID1A SMARCC2	4.77e-05	15	24	2	11263494
Pubmed	Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).	ARID1A SMARCC2	5.44e-05	16	24	2	11784859
Pubmed	A human RNA polymerase II complex containing factors that modify chromatin structure.	SMARCC2 EP300	5.44e-05	16	24	2	9710619
Pubmed	Identification of a polymorphic, neuron-specific chromatin remodeling complex.	ARID1A SMARCC2	6.17e-05	17	24	2	12368262
Pubmed	The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.	ARID1A SMARCC2	6.17e-05	17	24	2	11078522
Pubmed	A protein interaction landscape of breast cancer.	SEC24C ARID1A SS18 SMARCC2 SEC31A	6.32e-05	634	24	5	34591612
Pubmed	BAF complexes facilitate decatenation of DNA by topoisomerase IIα.	ARID1A SMARCC2	6.94e-05	18	24	2	23698369
Pubmed	mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.	ARID1A SMARCC2	6.94e-05	18	24	2	14559996
Pubmed	Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.	SMARCC2 EP300	6.94e-05	18	24	2	33323119
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SEC24C ARID1A ADNP SMARCC2 CHD7 SEC31A	7.44e-05	1082	24	6	38697112
Pubmed	Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes.	ARID1A SMARCC2	7.75e-05	19	24	2	12110891
Pubmed	BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells.	ARID1A SMARCC2	7.75e-05	19	24	2	18809673
Pubmed	Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction.	ARID1A SMARCC2	7.75e-05	19	24	2	16932743
Pubmed	Requirement for PBAF in transcriptional repression and repair at DNA breaks in actively transcribed regions of chromatin.	ARID1A SMARCC2	7.75e-05	19	24	2	25066234
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ARID1A ADNP FOXJ3 SMARCC2 EP300 CHD7	8.27e-05	1103	24	6	34189442
Pubmed	An epigenetic circuit controls neurogenic programs during neocortex development.	ARID1A SMARCC2	8.61e-05	20	24	2	35020876
Pubmed	The ULK1-FBXW5-SEC23B nexus controls autophagy.	SEC24C SEC31A	8.61e-05	20	24	2	30596474
Pubmed	Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway.	ARID1A SMARCC2	9.51e-05	21	24	2	20460684
Pubmed	Diversity and specialization of mammalian SWI/SNF complexes.	ARID1A SMARCC2	1.14e-04	23	24	2	8804307
Pubmed	The SWI/SNF chromatin-remodeling factor stimulates repair by human excision nuclease in the mononucleosome core particle.	ARID1A SMARCC2	1.25e-04	24	24	2	12215535
Pubmed	SWI/SNF chromatin remodeling and cancer.	ARID1A SMARCC2	1.25e-04	24	24	2	11790558
Pubmed	Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.	ARID1A SMARCC2	1.25e-04	24	24	2	10078207
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	SEC24C ARID1A SMARCC2 CHD7	1.44e-04	394	24	4	27248496
Pubmed	Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.	ARID1A SMARCC2	1.47e-04	26	24	2	10778858
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	ARID1A ADNP SMARCC2	1.49e-04	150	24	3	28242625
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ARID1A SMARCC2 EP300 CHD7	1.50e-04	398	24	4	35016035
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	ARID1A WBP2 SMARCC2	1.61e-04	154	24	3	16055720
Pubmed	Eda-activated RelB recruits an SWI/SNF (BAF) chromatin-remodeling complex and initiates gene transcription in skin appendage formation.	ARID1A SMARCC2	1.71e-04	28	24	2	30037996
Pubmed	Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin.	ATAT1 EP300	1.71e-04	28	24	2	31600191
Pubmed	REST repression of neuronal genes requires components of the hSWI.SNF complex.	ARID1A SMARCC2	1.71e-04	28	24	2	12192000
Pubmed	An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency.	ARID1A SMARCC2	1.83e-04	29	24	2	19279220
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	EIF4G3 ARID1A WBP2 EP300 CNOT3 SEC31A	1.91e-04	1285	24	6	35914814
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	SEC24C ARID1A SMARCC2 EP300	1.92e-04	425	24	4	24999758
Pubmed	Mammalian SWI/SNF collaborates with a polycomb-associated protein to regulate male germline transcription in the mouse.	ARID1A SMARCC2	1.96e-04	30	24	2	31043422
Interaction	TBXT interactions	ARID1A SS18 SMARCC2 EP300 CHD7	2.26e-07	116	24	5	int:TBXT
Interaction	HNF4A interactions	ARID1A ADNP SS18 SMARCC2 EP300 CHD7	6.69e-07	275	24	6	int:HNF4A
Interaction	ARID1A interactions	ARID1A ADNP SS18 SMARCC2 EP300 CHD7	6.84e-07	276	24	6	int:ARID1A
Interaction	APEX1 interactions	EIF4G3 ADGRB2 RBMS3 FOXJ3 SMARCC2 GORASP1 EP300 CNOT3 CHD7 SEC31A	8.34e-07	1271	24	10	int:APEX1
Interaction	GCM1 interactions	ARID1A SS18 SMARCC2 EP300	1.20e-06	68	24	4	int:GCM1
Interaction	SP7 interactions	ARID1A SS18 SMARCC2 EP300 CHD7 ZMIZ1	1.20e-06	304	24	6	int:SP7
Interaction	ETV4 interactions	ARID1A SS18 EP300 ZMIZ1	1.27e-06	69	24	4	int:ETV4
Interaction	SCYL1 interactions	SEC24C ARID1A SMARCC2 EP300 SEC31A	1.46e-06	169	24	5	int:SCYL1
Interaction	MYCN interactions	EIF4G3 SEC24C ARID1A ADNP RBMS3 SS18 SMARCC2 EP300 CHD7 SEC31A	1.69e-06	1373	24	10	int:MYCN
Interaction	SOX7 interactions	ARID1A SMARCC2 EP300 CHD7	2.54e-06	82	24	4	int:SOX7
Interaction	SMARCC2 interactions	ARID1A ADNP SS18 SMARCC2 EP300 CHD7	2.85e-06	353	24	6	int:SMARCC2
Interaction	IRF4 interactions	ARID1A SS18 EP300 CHD7	2.94e-06	85	24	4	int:IRF4
Interaction	GATA2 interactions	ARID1A SS18 SMARCC2 EP300 CHD7	3.26e-06	199	24	5	int:GATA2
Interaction	SS18 interactions	ARID1A SS18 SMARCC2 EP300	3.37e-06	88	24	4	int:SS18
Interaction	DPF3 interactions	ARID1A SS18 SMARCC2 EP300	4.58e-06	95	24	4	int:DPF3
Interaction	SOX9 interactions	ARID1A SMARCC2 EP300 CHD7	4.98e-06	97	24	4	int:SOX9
Interaction	SS18L1 interactions	ARID1A SS18 SMARCC2 EP300	5.18e-06	98	24	4	int:SS18L1
Interaction	ERG interactions	ARID1A SS18 SMARCC2 EP300 CHD7	5.68e-06	223	24	5	int:ERG
Interaction	GATA4 interactions	ARID1A SS18 SMARCC2 EP300 CHD7 SEC31A	6.84e-06	411	24	6	int:GATA4
Interaction	PAX8 interactions	ARID1A WBP2 EP300 CHD7	8.51e-06	111	24	4	int:PAX8
Interaction	FOXP3 interactions	EIF4G3 SEC24C ARID1A SMARCC2 EP300 CNOT3	9.09e-06	432	24	6	int:FOXP3
Interaction	TBR1 interactions	ARID1A EP300 CHD7 ZMIZ1	9.13e-06	113	24	4	int:TBR1
Interaction	RBPJ interactions	ADNP SMARCC2 EP300 CHD7 ZMIZ1	1.07e-05	254	24	5	int:RBPJ
Interaction	KLF1 interactions	ARID1A SMARCC2 EP300	1.12e-05	37	24	3	int:KLF1
Interaction	DDIT3 interactions	ARID1A SS18 SMARCC2 EP300	1.16e-05	120	24	4	int:DDIT3
Interaction	ETS1 interactions	ARID1A SMARCC2 EP300 ZMIZ1	1.20e-05	121	24	4	int:ETS1
Interaction	PAX7 interactions	ARID1A SS18 EP300 CHD7	1.32e-05	124	24	4	int:PAX7
Interaction	SMARCA4 interactions	ARID1A ADNP SS18 SMARCC2 EP300 CHD7	1.33e-05	462	24	6	int:SMARCA4
Interaction	RNF138 interactions	EIF4G3 ARID1A ADNP SMARCC2	1.36e-05	125	24	4	int:RNF138
Interaction	SMARCE1 interactions	ARID1A SS18 SMARCC2 EP300 CHD7	1.93e-05	287	24	5	int:SMARCE1
Interaction	ACTL6A interactions	ARID1A SS18 SMARCC2 EP300 CNOT3	1.99e-05	289	24	5	int:ACTL6A
Interaction	YAP1 interactions	ARID1A ADNP PKNOX2 WBP2 FOXJ3 SMARCC2 EP300 TAB3	2.49e-05	1095	24	8	int:YAP1
Interaction	ELF5 interactions	ARID1A SS18 EP300 CHD7	2.58e-05	147	24	4	int:ELF5
Interaction	ARID2 interactions	ARID1A SS18 SMARCC2 CHD7	3.02e-05	153	24	4	int:ARID2
Interaction	RUNX1 interactions	ARID1A WBP2 SMARCC2 EP300 CNOT3	3.44e-05	324	24	5	int:RUNX1
Interaction	CARM1 interactions	ARID1A SMARCC2 GLI2 EP300 SEC31A	3.49e-05	325	24	5	int:CARM1
Interaction	NFATC1 interactions	ARID1A ADNP SMARCC2 EP300	4.35e-05	168	24	4	int:NFATC1
Interaction	SRGAP3 interactions	ARID1A SMARCC2 CNOT3	4.62e-05	59	24	3	int:SRGAP3
Interaction	SMARCA2 interactions	ARID1A ADNP SS18 SMARCC2 EP300	4.71e-05	346	24	5	int:SMARCA2
Interaction	FLI1 interactions	ARID1A SS18 SMARCC2	5.36e-05	62	24	3	int:FLI1
Interaction	LHX2 interactions	ARID1A SS18 SMARCC2 CHD7	6.06e-05	183	24	4	int:LHX2
Interaction	BICRA interactions	ARID1A SS18 SMARCC2	6.76e-05	67	24	3	int:BICRA
Interaction	TLE3 interactions	ARID1A SMARCC2 GLI2 EP300 ZMIZ1	6.98e-05	376	24	5	int:TLE3
Interaction	MYOD1 interactions	ARID1A SS18 SMARCC2 EP300	7.61e-05	194	24	4	int:MYOD1
Interaction	SMARCC1 interactions	ARID1A SS18 SMARCC2 EP300 CHD7	7.72e-05	384	24	5	int:SMARCC1
Interaction	NFATC2 interactions	ARID1A ADNP SMARCC2 EP300	8.56e-05	200	24	4	int:NFATC2
Interaction	CNOT3 interactions	GLI2 EP300 CNOT3 TAB3	9.78e-05	207	24	4	int:CNOT3
Interaction	AR interactions	ARID1A ADNP SMARCC2 GLI2 EP300 CHD7 ZMIZ1	1.13e-04	992	24	7	int:AR
Interaction	WWTR1 interactions	ARID1A ADNP WBP2 EP300 TAB3	1.20e-04	422	24	5	int:WWTR1
Interaction	IRF1 interactions	ARID1A SS18 EP300	1.28e-04	83	24	3	int:IRF1
Interaction	FOXC1 interactions	ARID1A ADNP SMARCC2 EP300	1.42e-04	228	24	4	int:FOXC1
Interaction	SOX2 interactions	EIF4G3 ARID1A ADNP SS18 SMARCC2 EP300 CNOT3 CHD7	1.59e-04	1422	24	8	int:SOX2
Interaction	SEC31A interactions	SEC24C GORASP1 EP300 SEC31A	1.62e-04	236	24	4	int:SEC31A
Interaction	TRAPPC13 interactions	SEC24C EP300 SEC31A	1.74e-04	92	24	3	int:TRAPPC13
Interaction	SOX10 interactions	ARID1A EP300 CHD7	1.74e-04	92	24	3	int:SOX10
Interaction	EYA4 interactions	FOXJ3 EP300 TAB3 ZMIZ1	1.81e-04	243	24	4	int:EYA4
Interaction	SIRT7 interactions	EIF4G3 SEC24C ARID1A ADNP SMARCC2 CHD7	1.89e-04	744	24	6	int:SIRT7
Interaction	BCL7B interactions	ARID1A SS18 SMARCC2	1.91e-04	95	24	3	int:BCL7B
Interaction	SOX17 interactions	ARID1A SS18 CHD7	1.91e-04	95	24	3	int:SOX17
Interaction	DPF1 interactions	ARID1A SS18 SMARCC2	1.91e-04	95	24	3	int:DPF1
Interaction	ASF1A interactions	ARID1A SMARCC2 EP300 CHD7	1.99e-04	249	24	4	int:ASF1A
Interaction	MAN1B1 interactions	SEC24C EP300 SEC31A	2.03e-04	97	24	3	int:MAN1B1
Interaction	RAB1B interactions	SEC24C SMARCC2 EP300 SEC31A	2.11e-04	253	24	4	int:RAB1B
Interaction	CRX interactions	ARID1A EP300 CHD7 ZMIZ1	2.15e-04	254	24	4	int:CRX
Interaction	TFCP2L1 interactions	ARID1A ADNP SMARCC2	2.16e-04	99	24	3	int:TFCP2L1
Interaction	HDAC1 interactions	ARID1A ADNP SS18 SMARCC2 GLI2 EP300 ZMIZ1	2.26e-04	1108	24	7	int:HDAC1
Interaction	PBRM1 interactions	ARID1A SS18 SMARCC2 CHD7	2.28e-04	258	24	4	int:PBRM1
Interaction	ING1 interactions	ARID1A SMARCC2 EP300	2.43e-04	103	24	3	int:ING1
Interaction	TEX13B interactions	ARID1A SMARCC2	2.55e-04	20	24	2	int:TEX13B
Interaction	SMARCD3 interactions	ARID1A SS18 SMARCC2	2.72e-04	107	24	3	int:SMARCD3
Interaction	BCL7C interactions	ARID1A SS18 SMARCC2	3.36e-04	115	24	3	int:BCL7C
Interaction	RBBP5 interactions	ARID1A SMARCC2 EP300 CHD7	3.42e-04	287	24	4	int:RBBP5
Interaction	BRD9 interactions	ARID1A SS18 SMARCC2	3.53e-04	117	24	3	int:BRD9
Interaction	TRAPPC2L interactions	SEC24C EP300 SEC31A	3.99e-04	122	24	3	int:TRAPPC2L
Interaction	BCL7A interactions	ARID1A SS18 SMARCC2	4.09e-04	123	24	3	int:BCL7A
Interaction	TERF2IP interactions	ARID1A ADNP SMARCC2 CHD7 ARPP21	4.18e-04	552	24	5	int:TERF2IP
Interaction	TSG101 interactions	PKNOX2 GLI2 EP300 CHD7	4.20e-04	303	24	4	int:TSG101
Interaction	TEX13A interactions	SMARCC2 CNOT3	4.68e-04	27	24	2	int:TEX13A
Interaction	FOS interactions	ARID1A SS18 SMARCC2 EP300	4.69e-04	312	24	4	int:FOS
Interaction	IGF2R interactions	SEC24C GORASP1 EP300 SEC31A	4.80e-04	314	24	4	int:IGF2R
Interaction	PAX9 interactions	ARID1A EP300 CHD7	4.81e-04	130	24	3	int:PAX9
Interaction	SLC30A5 interactions	SEC24C EP300 SEC31A	5.14e-04	133	24	3	int:SLC30A5
Interaction	CHAF1A interactions	SEC24C ARID1A ADNP SMARCC2	5.28e-04	322	24	4	int:CHAF1A
Interaction	TRAPPC5 interactions	SEC24C EP300 SEC31A	5.37e-04	135	24	3	int:TRAPPC5
Interaction	SLC39A9 interactions	SEC24C EP300 SEC31A	5.48e-04	136	24	3	int:SLC39A9
Interaction	MECP2 interactions	SEC24C ARID1A ADNP SMARCC2 EP300 CHD7 SEC31A	5.63e-04	1287	24	7	int:MECP2
Interaction	PHF10 interactions	ARID1A SS18 SMARCC2	5.84e-04	139	24	3	int:PHF10
Interaction	RAB5C interactions	SEC24C SS18 CD99 EP300 SEC31A	6.11e-04	600	24	5	int:RAB5C
Interaction	HERC1 interactions	ATAT1 GLI2 EP300	6.48e-04	144	24	3	int:HERC1
Interaction	NUP50 interactions	ARID1A SMARCC2 CHD7 SEC31A	6.55e-04	341	24	4	int:NUP50
Interaction	DAZL interactions	EIF4G3 RBMS3 CNOT3	6.61e-04	145	24	3	int:DAZL
Interaction	KDM1A interactions	ADNP SMARCC2 EP300 CNOT3 CHD7 ZMIZ1	6.65e-04	941	24	6	int:KDM1A
Interaction	TERF1 interactions	FOXJ3 SMARCC2 EP300 ARPP21	6.99e-04	347	24	4	int:TERF1
Interaction	SMARCD1 interactions	ARID1A PKNOX2 SS18 SMARCC2	7.14e-04	349	24	4	int:SMARCD1
Interaction	CHD7 interactions	ARID1A SMARCC2 CHD7	7.29e-04	150	24	3	int:CHD7
Interaction	RTF1 interactions	ARID1A EP300 CNOT3	7.29e-04	150	24	3	int:RTF1
Interaction	NR3C1 interactions	ARID1A FOXJ3 SS18 SMARCC2 EP300 CHD7	7.98e-04	974	24	6	int:NR3C1
Interaction	BRD7 interactions	ARID1A SS18 SMARCC2 EP300 CHD7	8.01e-04	637	24	5	int:BRD7
Interaction	HNRNPD interactions	SEC24C SMARCC2 EP300 SEC31A ZMIZ1	8.07e-04	638	24	5	int:HNRNPD
Interaction	BAZ1A interactions	SEC24C SMARCC2 SEC31A	8.17e-04	156	24	3	int:BAZ1A
Cytoband	Ensembl 112 genes in cytogenetic band chr3p22	GORASP1 ARPP21	4.16e-03	184	24	2	chr3p22
Cytoband	Ensembl 112 genes in cytogenetic band chr10q22	SEC24C ZMIZ1	5.28e-03	208	24	2	chr10q22
Cytoband	Ensembl 112 genes in cytogenetic band chrXp22	CBLL2 CD99	7.53e-03	250	24	2	chrXp22
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	SMARCC2 CHD7	1.11e-03	53	17	2	532
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	EIF4G3 SEC24C ADGRB2 ARID1A RBMS3 FOXJ3 ZMIZ1	5.59e-06	807	24	7	M14594
Coexpression	GENTILE_RESPONSE_CLUSTER_D3	ADNP FOXJ3 ZMIZ1	1.53e-05	53	24	3	M11338
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	ARID1A WBP2 GORASP1 CNOT3	3.04e-05	199	24	4	M9964
Coexpression	GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	WBP2 SMARCC2 CD99 ZMIZ1	3.04e-05	199	24	4	M7865
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN	SMARCC2 CD99 EP300	3.86e-05	72	24	3	M40882
Coexpression	GENTILE_UV_HIGH_DOSE_DN	ADNP FOXJ3 SS18 ZMIZ1	1.29e-04	289	24	4	M13630
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	ARID1A SMARCC2 GLI2 EP300	4.01e-04	389	24	4	M6520
Coexpression	GSE13522_WT_VS_IFNAR_KO_SKIN_DN	GVINP1 CHD7 ZMIZ1	5.61e-04	178	24	3	M2925
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	ARID1A EP300 CHD7	5.80e-04	180	24	3	M8239
Coexpression	GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN	CD99 CHD7 ARPP21	7.21e-04	194	24	3	M6908
Coexpression	GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	PKNOX2 FOXJ3 CNOT3	7.31e-04	195	24	3	M8151
Coexpression	GSE45837_WT_VS_GFI1_KO_PDC_UP	ATAT1 EP300 ARPP21	7.31e-04	195	24	3	M9892
Coexpression	GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN	ARID1A GVINP1 SMARCC2	7.53e-04	197	24	3	M5475
Coexpression	GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP	ADGRB2 WBP2 CHD7	7.76e-04	199	24	3	M8105
Coexpression	GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	CD99 GORASP1 SEC31A	7.76e-04	199	24	3	M3194
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN	WBP2 SS18 SEC31A	7.76e-04	199	24	3	M3843
Coexpression	GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	ARID1A ADNP ZMIZ1	7.76e-04	199	24	3	M7374
Coexpression	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	EIF4G3 ARID1A ADNP	7.76e-04	199	24	3	M6060
Coexpression	GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP	ARID1A GORASP1 ZMIZ1	7.76e-04	199	24	3	M8769
Coexpression	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN	FOXJ3 CD99 ZMIZ1	7.87e-04	200	24	3	M9411
Coexpression	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN	ARID1A SS18 ZMIZ1	7.87e-04	200	24	3	M5991
Coexpression	GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	ADGRB2 CHD7 SEC31A	7.87e-04	200	24	3	M330
Coexpression	GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP	ADGRB2 CD99 ZMIZ1	7.87e-04	200	24	3	M9235
Coexpression	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP	EIF4G3 CHD7 SEC31A	7.87e-04	200	24	3	M7086
Coexpression	GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	ADNP WBP2 TAB3	7.87e-04	200	24	3	M6652
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN	ADNP FOXJ3 SS18	7.87e-04	200	24	3	M4041
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN	WBP2 CHD7 ZMIZ1	7.87e-04	200	24	3	M3823
Coexpression	GSE17721_LPS_VS_POLYIC_12H_BMDC_UP	FOXJ3 CNOT3 SEC31A	7.87e-04	200	24	3	M3814
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	9.94e-05	169	24	3	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	PKNOX2 RBMS3 GLI2	1.18e-04	179	24	3	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-2\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GORASP1 CHD7 TAB3	1.22e-04	181	24	3	75035a3211e524bb659b82e6979f7d3a3121ae70
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.28e-04	184	24	3	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.28e-04	184	24	3	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	PKNOX2 RBMS3 GLI2	1.32e-04	186	24	3	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.38e-04	189	24	3	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.38e-04	189	24	3	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	PKNOX2 RBMS3 GLI2	1.41e-04	190	24	3	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.41e-04	190	24	3	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.41e-04	190	24	3	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.43e-04	191	24	3	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.43e-04	191	24	3	1caf726bd07fdca389e678fc16304a6ef1790423
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CD99 ARPP21 ZMIZ1	1.43e-04	191	24	3	40813c397f533c2f4a6359a77757f736b6d9e07d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.43e-04	191	24	3	3d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	PKNOX2 RBMS3 GLI2	1.43e-04	191	24	3	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PKNOX2 RBMS3 GLI2	1.43e-04	191	24	3	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	B_cell_maturation-CD34+_pre-plamsa\|B_cell_maturation / Lineage and Cell class	CD99 ARPP21 ZMIZ1	1.43e-04	191	24	3	4ee160a863d4fb9c4c9449633b9f337db8871992
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.43e-04	191	24	3	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PKNOX2 RBMS3 GLI2	1.45e-04	192	24	3	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.45e-04	192	24	3	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.45e-04	192	24	3	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PKNOX2 RBMS3 GLI2	1.47e-04	193	24	3	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PKNOX2 RBMS3 GLI2	1.47e-04	193	24	3	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.49e-04	194	24	3	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.49e-04	194	24	3	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.49e-04	194	24	3	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.49e-04	194	24	3	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.49e-04	194	24	3	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.49e-04	194	24	3	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.52e-04	195	24	3	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PKNOX2 RBMS3 GLI2	1.52e-04	195	24	3	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ATAT1 CHD7 ARPP21	1.54e-04	196	24	3	fe2dd3a93fe22da93e24a400e154a68757985fc8
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PKNOX2 RBMS3 GLI2	1.54e-04	196	24	3	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PKNOX2 RBMS3 GLI2	1.54e-04	196	24	3	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	PKNOX2 RBMS3 GLI2	1.56e-04	197	24	3	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	PKNOX2 RBMS3 GLI2	1.56e-04	197	24	3	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PKNOX2 RBMS3 GLI2	1.59e-04	198	24	3	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	PKNOX2 RBMS3 GLI2	1.59e-04	198	24	3	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PKNOX2 RBMS3 GLI2	1.59e-04	198	24	3	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	PKNOX2 RBMS3 GLI2	1.61e-04	199	24	3	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PKNOX2 RBMS3 GLI2	1.63e-04	200	24	3	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	ATAT1 ADNP ARPP21	1.63e-04	200	24	3	7bba2ff09349c8db3d1ccf53520b12cbf7b0abac
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PKNOX2 RBMS3 GLI2	1.63e-04	200	24	3	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Cortical_neuron\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	ATAT1 WBP2	1.70e-04	36	24	2	25fd4cf19f2ed94f99600c18383b17f86bb17ef5
Computational	Neighborhood of UBE2N	ARID1A ADNP WBP2 ZMIZ1	1.64e-04	154	20	4	GCM_UBE2N
Computational	Neighborhood of MYST2	ARID1A ADNP FOXJ3 ZMIZ1	2.51e-04	172	20	4	GCM_MYST2
Computational	Neighborhood of DDB1	SS18 SMARCC2 CNOT3 SEC31A	9.72e-04	246	20	4	MORF_DDB1
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP SS18 EP300 CNOT3	7.20e-07	173	23	5	4237_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP SS18 EP300 CNOT3	8.29e-07	178	23	5	4184_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	ARID1A ADNP FOXJ3 EP300 ZMIZ1	8.76e-07	180	23	5	4541_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300 ZMIZ1	2.27e-05	168	23	4	3868_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300 ZMIZ1	2.32e-05	169	23	4	5231_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	ARID1A ADNP EP300 ZMIZ1	2.38e-05	170	23	4	1050_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300 CNOT3	2.38e-05	170	23	4	3746_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ARID1A ADNP EP300 ZMIZ1	2.49e-05	172	23	4	1072_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300 ZMIZ1	2.60e-05	174	23	4	1659_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP SS18 EP300	2.60e-05	174	23	4	5065_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EIF4G3 ARID1A ADNP ZMIZ1	2.72e-05	176	23	4	6932_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP SS18 ZMIZ1	2.72e-05	176	23	4	7499_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300 ZMIZ1	2.79e-05	177	23	4	1645_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300 ZMIZ1	2.79e-05	177	23	4	6434_DN
Drug	SAHA; Down 200; 10uM; PC3; HT_HG-U133A	ARID1A ADNP EP300 CNOT3	2.85e-05	178	23	4	4444_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300 ZMIZ1	2.97e-05	180	23	4	4821_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300 ZMIZ1	3.04e-05	181	23	4	6951_DN
Drug	Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300 CHD7	3.24e-05	184	23	4	5671_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	ADGRB2 WBP2 GLI2 CNOT3	3.99e-05	194	23	4	4331_DN
Drug	Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A	ARID1A SS18 SMARCC2 CHD7	4.15e-05	196	23	4	5061_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HG-U133A	SEC24C PKNOX2 GLI2 EP300	4.15e-05	196	23	4	325_DN
Drug	A-skin	CD99 EP300	4.75e-04	32	23	2	CID000208772
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	5.74e-04	163	23	3	5594_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	5.95e-04	165	23	3	5625_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	5.95e-04	165	23	3	6085_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	5.95e-04	165	23	3	2835_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.05e-04	166	23	3	2247_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.16e-04	167	23	3	5217_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.38e-04	169	23	3	5572_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.38e-04	169	23	3	6064_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	6.49e-04	170	23	3	7043_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP CNOT3	6.49e-04	170	23	3	3791_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.49e-04	170	23	3	5417_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ARID1A ADNP EP300	6.60e-04	171	23	3	1000_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	6.60e-04	171	23	3	6879_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.60e-04	171	23	3	5441_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.71e-04	172	23	3	7179_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.71e-04	172	23	3	3428_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	6.71e-04	172	23	3	2794_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP CNOT3	6.71e-04	172	23	3	5903_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.71e-04	172	23	3	4112_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	6.83e-04	173	23	3	5987_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300	6.83e-04	173	23	3	5950_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.83e-04	173	23	3	3243_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300	6.83e-04	173	23	3	4458_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	ARID1A ADNP CNOT3	6.94e-04	174	23	3	7105_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300	6.94e-04	174	23	3	5745_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.94e-04	174	23	3	3462_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.94e-04	174	23	3	6579_DN
Drug	HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	ARID1A ADNP EP300	6.94e-04	174	23	3	909_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.94e-04	174	23	3	5693_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	6.94e-04	174	23	3	5580_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ARID1A ADNP EP300	7.06e-04	175	23	3	1058_DN
Drug	SAHA; Down 200; 10uM; PC3; HT_HG-U133A	ARID1A ADNP CNOT3	7.06e-04	175	23	3	1220_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	7.06e-04	175	23	3	5935_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.06e-04	175	23	3	6891_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ARID1A ADNP EP300	7.06e-04	175	23	3	1014_DN
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.18e-04	176	23	3	6179_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.18e-04	176	23	3	5976_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.18e-04	176	23	3	6980_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.18e-04	176	23	3	6784_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ARID1A ADNP CHD7	7.18e-04	176	23	3	981_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	7.30e-04	177	23	3	7550_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.30e-04	177	23	3	6551_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	7.30e-04	177	23	3	3227_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.30e-04	177	23	3	5308_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300	7.30e-04	177	23	3	7047_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP EP300	7.42e-04	178	23	3	4710_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.42e-04	178	23	3	1672_DN
Drug	fisetin; Down 200; 50uM; PC3; HG-U133A	ARID1A ADNP ZMIZ1	7.42e-04	178	23	3	579_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.42e-04	178	23	3	6193_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300	7.54e-04	179	23	3	6609_DN
Drug	scriptaid; Down 200; 10uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.54e-04	179	23	3	6901_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300	7.54e-04	179	23	3	5822_DN
Drug	trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A	ARID1A ADNP ZMIZ1	7.54e-04	179	23	3	331_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.54e-04	179	23	3	5484_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300	7.66e-04	180	23	3	3688_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.66e-04	180	23	3	5511_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	EIF4G3 ARID1A ADNP	7.66e-04	180	23	3	1793_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	ARID1A ADNP EP300	7.66e-04	180	23	3	6886_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	7.78e-04	181	23	3	3643_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EIF4G3 ARID1A ADNP	7.78e-04	181	23	3	7005_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ARID1A ADNP CHD7	7.91e-04	182	23	3	3887_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ARID1A ADNP CHD7	8.16e-04	184	23	3	2321_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	ARID1A ADNP ZMIZ1	8.16e-04	184	23	3	6939_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	ARID1A ADNP CHD7	8.29e-04	185	23	3	1114_DN
Drug	2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A	ARID1A ADNP EP300	8.82e-04	189	23	3	410_DN
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	ARID1A FOXJ3 SS18	9.09e-04	191	23	3	1227_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A	ADGRB2 SS18 CNOT3	9.23e-04	192	23	3	4334_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; MCF7; HT_HG-U133A	FOXJ3 SS18 CNOT3	9.23e-04	192	23	3	2624_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARID1A SS18 SMARCC2	9.37e-04	193	23	3	1644_DN
Drug	trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A	ARID1A ADNP ZMIZ1	9.37e-04	193	23	3	413_DN
Drug	Bromperidol [10457-90-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ARID1A PKNOX2 CNOT3	9.37e-04	193	23	3	2872_UP
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	ARID1A SS18 CHD7	9.37e-04	193	23	3	6646_DN
Drug	Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A	FOXJ3 SS18 CHD7	9.51e-04	194	23	3	2118_DN
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PKNOX2 RBMS3 ARPP21	9.51e-04	194	23	3	4182_UP
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A	ARID1A WBP2 SMARCC2	9.66e-04	195	23	3	1630_UP
Drug	Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ARID1A PKNOX2 SS18	9.66e-04	195	23	3	3212_UP
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	EIF4G3 SS18 SMARCC2	9.66e-04	195	23	3	5307_DN
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	ADGRB2 RBMS3 SS18	9.66e-04	195	23	3	1815_UP
Disease	free androgen index	ARID1A PKNOX2 RBMS3 CHD7 ZMIZ1	8.88e-06	374	23	5	EFO_0007005
Disease	Coffin-Siris syndrome (implicated_via_orthology)	ARID1A SMARCC2	2.09e-05	9	23	2	DOID:1925 (implicated_via_orthology)
Disease	Coffin-Siris syndrome	ARID1A SMARCC2	4.51e-05	13	23	2	C0265338
Disease	prostate carcinoma	ATAT1 ADNP PKNOX2 CHD7 TAB3 ZMIZ1	4.84e-05	891	23	6	EFO_0001663
Disease	T-Cell Lymphoma	ARID1A EP300	6.93e-05	16	23	2	C0079772
Disease	testosterone measurement	ARID1A PKNOX2 RBMS3 SS18 CHD7 ZMIZ1	3.44e-04	1275	23	6	EFO_0004908
Disease	alcohol use disorder (implicated_via_orthology)	ARID1A SMARCC2 EP300	4.57e-04	195	23	3	DOID:1574 (implicated_via_orthology)
Disease	Breast adenocarcinoma	ARID1A EP300	4.68e-04	41	23	2	C0858252
Disease	Neoplasm of uncertain or unknown behavior of breast	ARID1A EP300	4.68e-04	41	23	2	C0496956
Disease	Carcinoma, Transitional Cell	ARID1A EP300	4.68e-04	41	23	2	C0007138
Disease	Diffuse Large B-Cell Lymphoma	EP300 SEC31A	8.42e-04	55	23	2	C0079744
Disease	Endometrial Neoplasms	ARID1A EP300	9.36e-04	58	23	2	C0014170
Disease	PROSTATE CANCER, HEREDITARY, 1	ATAT1 PKNOX2	1.00e-03	60	23	2	C4722327
Disease	age at menarche	EIF4G3 ARID1A RBMS3 FOXJ3	1.06e-03	594	23	4	EFO_0004703
Disease	pyruvate measurement	RBMS3 GLI2 TAB3	1.15e-03	268	23	3	EFO_0010117
Disease	Alcoholic Intoxication, Chronic	PKNOX2 GLI2 EP300	1.15e-03	268	23	3	C0001973
Disease	neutrophil percentage of leukocytes	ARID1A CHD7 SEC31A ZMIZ1	1.17e-03	610	23	4	EFO_0007990
Disease	Colorectal Neoplasms	ARID1A EP300 ZMIZ1	1.26e-03	277	23	3	C0009404
Disease	Prostate cancer, familial	ATAT1 PKNOX2	1.32e-03	69	23	2	C2931456
Disease	Endometrial Carcinoma	ARID1A EP300	1.44e-03	72	23	2	C0476089
Disease	asparaginase hypersensitivity	CNOT3 ZMIZ1	1.64e-03	77	23	2	EFO_0004881
Disease	C-reactive protein measurement	EIF4G3 SMARCC2 CHD7 ARPP21 ZMIZ1	2.06e-03	1206	23	5	EFO_0004458
Disease	Adenoid Cystic Carcinoma	ARID1A EP300	2.75e-03	100	23	2	C0010606
Disease	eosinophil measurement	CHD7 ZMIZ1	3.19e-03	108	23	2	EFO_0803540

Protein segments in the cluster

Peptide	Gene	Start	Entry
QNPYGMTFQPPPPTP	ADGRB2	1416	O60241
YHAQNNPPVPPKPQP	ADNP	581	Q9H2P0
QPPHSSPSPRMQPQP	EP300	2321	Q09472
NPPMAPPNPRYSHNV	GVINP1	1676	Q7Z2Y8
NPPKPMPNPNPNHPS	CD99	71	P14209
PSPSSPVNHQMPYPP	CBLL2	286	Q8N7E2
SYPNMPHPQPSHQPP	CHD7	426	Q9P2D1
PVYPSSLMPQPAQQP	ARPP21	576	Q9UBL0
NPCPTPPYHHQMPPP	CNOT3	641	O75175
QSYAPAPHPMAPPSP	RBMS3	26	Q6XE24
QPSQPPHQQSPAPYP	ARID1A	521	O14497
RPPPSNYQPPPSMQN	ARID1A	1566	O14497
GVPPPHPVQSYPQQS	GLI2	1311	P10070
PHFMETPLQPPPPVQ	GORASP1	286	Q9BQQ3
PSVMPPPGYPHIPQA	FOXJ3	561	Q9UPW0
PMHTAPPQAPAPPAQ	ATAT1	381	Q5SQI0
PLPPMHSPQQPGYQP	SEC24C	266	P53992
VNHLPMPYPVPQGPQ	EIF4G3	51	O43432
TQNVPPPPYQDSPQM	PKNOX2	16	Q96KN3
MPPSPSTTPPHPYQQ	TAB3	321	Q8N5C8
HGPSPFPNQQTPPSM	SMARCC2	1046	Q8TAQ2
NQSGPPPPPRSHNMP	SS18	91	Q15532
PGHMHTQVPPYPQPQ	SEC31A	861	O94979
NYPHSPVPGNPTPPM	ZMIZ1	506	Q9ULJ6
NPHNVYMPTSQPPPP	WBP2	236	Q969T9